News
We recently published a list of 11 Best Medical Device Stocks to Buy Now. In this article, we are going to take a look at ...
The US Food and Drug Administration (FDA) has set an "aggressive" timeline to implement generative artificial intelligence (genAI) across the agency by 30 June 2025. According to the agency, the ...
3hon MSN
We recently published a list of Billionaire David Abrams’ 10 Stock Picks with Huge Upside Potential. In this article, we are ...
Here is our list of the 10 best cancer stocks to invest in for long term gains. Summit Therapeutics Inc. (NASDAQ:SMMT) is a ...
Donald Trump has promised to create a pro-AI environment, but even tech companies are frustrated by federal cuts that hamper regulatory processes. Paul Webster reports.
FDA's plan to deploy an AI tool to assist with scientific review process raises questions about transparency and risks.
Accesses deep domain experience and capabilities from EY to help transform critical functions across the entire enterprise.Delivers an EY managed service solution embedded with AI capabilities ...
The U.S. Food and Drug Administration said on Thursday all its centers will deploy artificial intelligence internally ...
The Food and Drug Administration on Thursday announced an aggressive agency-wide Artificial intelligence adoption timeline ...
The U.S. Food and Drug Administration (FDA) on Thursday announced an expedited plan to implement artificial intelligence (AI) ...
The FDA is gathering up AI talent. The Food and Drug Administration is bringing on new artificial intelligence talent and ...
The Food and Drug Administration is going all in on artificial intelligence. | The Food and Drug Administration is going all ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results